Secunderabad, India

Arundutt Viswanatham Silamkoti

This inventor holds 7 USPTO granted patents. Top assignee: Ranbaxy Laboratories, Inc.. Active years: 2007-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arundutt Viswanatham Silamkoti. Retrieved from https://idiyas.com/inventor/arundutt-viswanatham-silamkoti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 14.3

Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2007-2009

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Arundutt Viswanatham Silamkoti - Pioneering Inventor from Secunderabad

Introduction: Arundutt Viswanatham Silamkoti is a distinguished inventor hailing from Secunderabad, India, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Arundutt Viswanatham Silamkoti holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Arundutt Viswanatham Silamkoti has worked with leading tech companies and research institutions, consistently pushing the boundaries of what is possible in the realm of invention.

Collaborations: Throughout his career, Arundutt Viswanatham Silamkoti has collaborated with top scientists, engineers, and researchers from around the world, fostering a culture of innovation and knowledge-sharing.

Conclusion: Arundutt Viswanatham Silamkoti's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…